APA

Schöffski P., Herr A., Vermorken J. B., Van den Brande J., Beijnen J. H., Rosing H., Volk J., Ganser A., Adank S., Botma H. J. & Wanders J. (20020627). Clinical phase II study and pharmacological evaluation of rubitecan in non-pretreated patients with metastatic colorectal cancer-significant effect of food intake on the bioavailability of the oral camptothecin analogue. : European journal of cancer (Oxford, England : 1990).

Chicago

Schöffski P, Herr A, Vermorken J B, Van den Brande J, Beijnen J H, Rosing H, Volk J, Ganser A, Adank S, Botma H J and Wanders J. 20020627. Clinical phase II study and pharmacological evaluation of rubitecan in non-pretreated patients with metastatic colorectal cancer-significant effect of food intake on the bioavailability of the oral camptothecin analogue. : European journal of cancer (Oxford, England : 1990).

Harvard

Schöffski P., Herr A., Vermorken J. B., Van den Brande J., Beijnen J. H., Rosing H., Volk J., Ganser A., Adank S., Botma H. J. and Wanders J. (20020627). Clinical phase II study and pharmacological evaluation of rubitecan in non-pretreated patients with metastatic colorectal cancer-significant effect of food intake on the bioavailability of the oral camptothecin analogue. : European journal of cancer (Oxford, England : 1990).

MLA

Schöffski P, Herr A, Vermorken J B, Van den Brande J, Beijnen J H, Rosing H, Volk J, Ganser A, Adank S, Botma H J and Wanders J. Clinical phase II study and pharmacological evaluation of rubitecan in non-pretreated patients with metastatic colorectal cancer-significant effect of food intake on the bioavailability of the oral camptothecin analogue. : European journal of cancer (Oxford, England : 1990). 20020627.